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Abstract 
 
We present a case of chronic meningitis due to the mold Aureobasidium 
proteae. Clinical features, the disease course, as well as the diagnostic methods and optimal treatment 
options are discussed. This case confirms neuroinvasiveness of Aureobasidium proteae and introduces 
it as a new human pathogen. 
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1. Introduction 
 
Cerebral phaeohyphomycosis is central nervous system (CNS) infection caused by 
dematiaceous fungi. Specific characteristic of these fungi is the presence of melanin pigments in the 
cell walls and spores. They are found throughout the world in soil and decaying vegetation. The usual 
pathogens that are clinically significant include: Cladophialophora bantiana, Exophiala dermatitidis, 
Ochroconis gallopavum, Fonsecaea pedrosoi, Ramichloridium mackenziei and Aureobasidium species 
(Chang et al., 2000; Tintelnot et al., 1991; Vukmir et al., 1994; Sides et al., 1991; al-Hedaithy et al., 
1988; Sutton et al., 1998). 
Most common pathogenesis of cerebral phaeohyphomycosis is the extension of infection from 
adjacent paranasal sinuses after the inhalation of spores. In one case report hematogenous 
dissemination from a localized skin lesion has been suggested (Fletcher et al., 2000). The usual 
clinical presentation of cerebral phaeohyphomycosis is a brain abscess with seizures and focal 
neurological deficits.  
Cerebral phaeohyphomycosis can occur in immunocompetent and immunocompromised 
patients equally and overall mortality in a major review article was 73% (Revankar et al., 2004). 
Suggested medical treatment of this disease consists of amphotericin B in combination with an azole. 
Surgical resection is mandatory if the brain abscesses are present (Revankar et al., 2004). 
Aureobasidium species are molds known to cause fungemia, eye and skin infections (Hawkes 
et al., 2005). The only member of the species reported to cause meningitis is Aureobasidium mansoni 
(Krcméry et al., 1994;  Huttova et al., 1998) 
We present a case of chronic meningitis caused by Aureobasidium protae. This mold has not 
been reported as a human or CNS pathogen in the literature thus far. 
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2. Case report 
 
A 53-year old white male was admitted to our hospital because of suspected chronic 
meningitis. His illness started three months prior to the admission with fever, weight loss, headache, 
dark colored facial skin lesion and progressive hearing loss. He is an agricultural worker in charge of 
planting and harvesting crops. 
At admission he was febrile with preserved consciousness and severe bilateral hearing loss 
without any signs of the vestibular system involvement. Neurologic examination was otherwise 
unremarkable. Dark colored painless skin ulcer with elevated erythematous edges was noticed on his 
left cheek. Remaining physical examination was normal. 
Lumbar puncture yielded normotensive opalescent cerebrospinal fluid (CSF) containing 420 
white cells per cubic millimeter, with 54% neutrophils and without eosinophils. CSF-blood glucose 
ratio was 0.36, protein content was 1.337 g/L and chloride level was normal. Gram and acid-fast stain 
of the CSF were negative and the CSF remained sterile. White blood cell count was 7.3 × 10
9
/L with 
normal differential, platelet count 291 × 10
9
/L, and hemoglobin level 9.0 g/dL. Erythrocyte 
sedimentation rate (ESR) was 100 mm/h with C-reactive protein of 104.3 mg/L. A native and contrast-
enhanced brain computed tomography scan and the Magnetic Resonance Imaging (MRI) of the brain 
at admission were normal. 
Excision biopsy specimen of the facial lesion showed granulomatous inflammation on 
hematoxylin-eosin stain. The attempt of fungal isolation from this specimen was unsuccessful. 
CD4 count was normal and the patient tested negative on the anti-HIV antibody assay. 
Electrophoresis of the serum proteins as well as immunoelectrophoresis revealed normal results. 
Pathological uptake of fluorodeoxyglucose was not detected on the positron emission 
tomography - computed tomography of the whole body. 
Anti-nuclear and anti double-stranded DNA antibodies were negative. Anti-neutrophil 
cytoplasmic antibodies and rheumatoid factor were negative as well. 
CSF formula was compatible with tuberculous meningitis, thus CSF samples were taken daily 
for four consecutive days in order to increase the sensitivity of Mycobacterim tubercoulosis cultures. 
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All four CSF samples grew Aureobasidium pullulans. Sabouraud's glucose agar with chloramphenicol 
and Brainheart infusion agar were used for fungal isolation from the CSF. 
Further molecular biology analysis of the isolated pathogen ensued. Suspensions were 
prepared from the cultures in double distilled water (108 cells/ml) and used as template DNA for 
subsequent polymerase chain reaction (PCR) amplification. PCR-amplification of the internal 
transcribed spacer region was carried out (Rigó et al., 2002). The sequences of the PCR products were 
determined as described in the literature (Voncina et al., 2011). The gained sequences were analyzed 
by NCBI Standard Nucleotide BLAST (http://blast.ncbi.nlm.nih.gov/), then aligned by the aid of 
softwares ClustalX2 and GeneDoc in comparison with the corresponding sequences of 2-2 
A. pullulans and A. proteae strains (GenBank accession numbers: JN400825.1, EF567985.1 and 
JN712493.1, JN712492.1, respectively). BLAST analysis revealed 99% homology of the ITS 
sequences of the isolates both to those of A. pullulans and A. proteae. Results of the alignments 
showed clear difference from A. pullulans while complete identity with each other and with both 
A. proteae strains tested, suggesting that all the four isolates belong to this species. 
Three weeks after admission the susceptibility testing confirmed that the isolate was sensitive 
to both amphotericin B and voriconazole. The E-test was performed and revealed minimal inhibitory 
concentrations of 0.06 and 0.03 µg/ml for amphotericin B and voriconazole respectively. 
After the samples were collected the empirical antifungal treatment with amphotericin B and 
voriconazole commenced. Subsequently, the patients’ condition gradually improved. His hearing 
started to improve after 12 day of treatment and was clinically completely recovered at the discharge 
from the hospital. The fever resolved after 10 days of treatment and the CSF examination was normal 
after a month. Inflammation markers, ESR and C-reactive protein returned to normal values at 
discharge. Facial skin lesion resolved promptly and completely on topical twice daily clotrimazole 
treatment and systemic antifungal treatment. The patient was discharged from the hospital after two 
months without any signs of the disease. Peroral voriconazole treatment of 400 mg bid was 
recommended for additional four months. 
After four months patient was hospitalized again for reevaluation of the disease and was found 
to be cured from the meningitis. However, during the hospital stay he suffered from the ruptured 
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aneurysm of the abdominal aorta and died of hemorrhagic shock. The only significant finding on 
the post-mortem analysis was ruptured aneurysm of the abdominal aorta and large 
retroperitoneal hematoma. 
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3. Discussion 
 
We report a case of A. proteae cerebral phaeohyphomycosis that presented as 
chronic meningitis. Extensive search was undertaken in order to detect any medical condition that 
could predispose the patient to the A. proteae infection and unveiled nothing significant. 
Consequently, it can be concluded that this pathogen can cause infection in immunocompetent adult 
patients. 
Proposed pathogenesis in the presented case is hematogenous dissemination to the CNS. 
Facial lesion could be the source of the infection since the biopsy specimen confirmed granulomatous 
inflammation compatible with the fungal etiology. Regardless of the exact pathogenic mechanism, 
this case definitely confirms neuroinvasiveness of A. proteae and introduces this mold as a new human 
as well as CNS pathogen. 
The new-onset of deafness does not indicate any etiology and can be a consequence of 
bacterial, fungal and tuberculous meningitis. However, since it affected our patient it could be 
perceived as one of the features that occur during the A. protae meningitis and could be attributed to 
the basal form of meningitis. Furthermore, the skin biopsy of any suspicious lesion could be helpful in 
similar patients since it might indicate the fungal etiology. 
The prompt etiological diagnosis is required for the implementation of the most effective 
antifungal treatment. Due to the absolute lack of experience with this mold as a human pathogen, we 
can only propose the treatment protocol used in the described patient. The treatment consisted of 
conventional amphotericin B 1 mg/kg daily for two weeks. Voriconazole was added concomitantly 
with initial dose of 6 mg/kg every 12 hours for 2 doses, afterwards the maintenance dose of 4 mg/kg 
every 12 hours for four weeks was administered. Initial parenteral treatment was followed by peroral 
voriconazole (400 mg bid) for the next four months. Voriconazole has the best CNS penetration and is 
thus preferred over the other extended-spectrum azoles. This treatment approach should be reevaluated 
if the cases of A. proteae meningitis occur in the future. However, until the time arrives we can 
recommend the treatment presented since it completely cured meningitis in our patient 
without any significant side-effects occurring. 
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